Animal Health AngelsLogin

Our Angels invest in brilliant businesses destined to make animal health care better.

Home Hero

Drawing on a unique blend of investment expertise and extensive animal health experience, we're here to empower visionary owners. Promote true innovation. Connect like-minded leaders. And to provide the support that can ignite an entrepreneurial idea into a world of progress.

People collaborating

Entrepreneurs

Ready to ignite your idea?

If you're in the early stages of an innovative animal health business – brimming with potential, then we'd love the chance to chat with you. Just imagine... our passion for great ideas blended with your entrepreneurial spirit.

We can't wait to partner with you, to propel your vision forward. Let's embark on this journey together – let's talk!


Laboratory testing

Angel Investors

Ready to fuel progress?

If you're an up-and-coming or well-versed investor, on the lookout for exciting and innovative ideas to back, we'd love to meet you. Your experience and insight will make you a valuable addition to our Angel Investor team.

Join us, as we support and drive innovative animal health businesses towards success.


  1. Photon Therapeutics

    Photon Therapeutics Wins Technology and Innovation Award at AHNTI EU Innovation Showcase 2026

    Photon Therapeutics, has been named the winner of the Technology Award at the AHNTI EU Innovation Showcase 2026, recognising its breakthrough approach to advancing animal health innovation.

  2. Bioaz

    BioAZ raises $1M to accelerate biotech innovation for animal well-being

    BioAZ is proud to announce a $1M (€900k) fundraising round with the support of its historical shareholders and leading veterinary business angels.

  3. MI:RNA

    Multi-million dollar funding round accelerates MI:RNA mission to improve global veterinary diagnostics

    Pioneering molecular diagnostics company MI:RNA, which uses biomarkers and advanced modelling to diagnose veterinary disease earlier, has reached a growth milestone with the completion of an oversubscribed funding round.